BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Abbott Laboratories (ABT) And Axis Shield PLC (ASD.L) Announce U.S. 510(k) Submission And International Launch Of AxSYM Testosterone Assay


10/19/2005 5:08:59 PM

ABBOTT PARK, Ill., July 13 /PRNewswire-FirstCall/ -- Abbott Laboratories today announced that its manufacturing partner, Axis-Shield, has submitted a 510(k) Premarket Notification with the U.S. Food and Drug Administration (FDA) seeking clearance of a Testosterone test for use on Abbott's AxSYM(R) automated immunoassay instrument system. In April, Abbott introduced the test in the other major markets throughout the world.

"Expanding diagnostic test menus across our instrument systems continues to be a top priority," said William Brown, Ph.D., vice president, Diagnostic Assays and Systems Development, Abbott Laboratories. "Like other AxSYM assays we've introduced this year, this test increases our AxSYM offerings and will enhance our fertility panel."

The AxSYM immunoassay system can process up to 80 to 120 tests per hour allowing medium-volume clinical laboratories to process a variety of immunodiagnostic tests simultaneously. Besides fertility, other test menus include assays for abused drugs, cancer, cardiac, endocrinology, hepatitis, infectious disease, metabolic/renal, therapeutic drug monitoring and toxicology.

About Axis-Shield

Axis-Shield is a global manufacturer of in vitro diagnostic kits with a focus on new markers in cardiovascular, rheumatoid, infectious and alcohol- related diseases, diabetes, dementia and near patient testing to facilitate improved patient management. Axis-Shield has partnered with Abbott to introduce several new tests on both the IMx(R) and AxSYM(R) systems, Abbott's market-leading automated immunoassay analyzers. News releases and company information are available at http://www.axis-shield.com/ .

About Abbott Laboratories

Abbott Laboratories is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical and medical products, including nutritionals, devices and diagnostics. The company employs more than 55,000 people and markets its products in more than 130 countries.

Abbott 's news releases and other information are available on the company's Web site at http://www.abbott.com/ .

Abbott Laboratories

CONTACT: Media, Amy Woodworth, +1-847-935-4755, or Financial Community,Christy Wistar, +1-847-938-4475, both of Abbott



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES